Acute Lymphoid Leukemia (ALL)
Oncology·MeSH: Anemia, Refractory, with Excess of Blasts
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Acute Lymphoid Leukemia (ALL)?
There are 1 clinical trial targeting Acute Lymphoid Leukemia (ALL) tracked by BioSniper.
What is the prevalence of Acute Lymphoid Leukemia (ALL)?
The estimated prevalence of Acute Lymphoid Leukemia (ALL) is approximately 30.0 per 100,000 population.
Deep-dive into Acute Lymphoid Leukemia (ALL)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis